Seventh amended and restated investors rights agreement providing registration, information, first offer and first refusal rights; most rights terminated at IPO.
| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Chad Robins
Also a director
Chief Executive Officer and Chairman
|
51 | Not stated | Not stated | $9,081,690 | |
|
Kyle Piskel
Chief Financial Officer
|
42 |
Since 2024
2 years
|
2015 | $3,310,729 | |
|
Julie Rubinstein
President and Chief Operating Officer
|
54 | Not stated | Not stated | $4,603,995 | |
|
Francis Lo
Chief People Officer
|
45 |
Since 2019
7 years
|
Not stated | Not reported | |
|
Harlan Robins
Chief Scientific Officer
|
53 | Not stated | Not stated | $8,509,575 | |
|
Susan Bobulsky
Chief Commercial Officer, MRD
|
45 |
Since 2024
2 years
|
2014 | $3,547,558 | |
|
Sharon Benzeno
Chief Commercial Ofc Imm Med
Title from the Form 4 dated Jun 26, 2026
|
52 | Not stated | Not stated | Not reported |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Seventh amended and restated investors rights agreement providing registration, information, first offer and first refusal rights; most rights terminated at IPO.
Purchased 250,000 shares of DigitalBio common stock (2.5% interest) in March 2021.
Purchased 250,000 shares of DigitalBio common stock (2.5% interest) in March 2021.
Purchased 500,000 shares of DigitalBio common stock (5% interest) in March 2021.
Purchased an aggregate of 2,000,000 shares of DigitalBio common stock (20% interest) in March 2021.
Participated in DigitalBio Series A Preferred Stock financing, purchasing an aggregate of 557,142 shares (about 4% of DigitalBio).
Indemnification agreements requiring the company to indemnify directors and certain executive officers for expenses, judgments, fines and settlements.
Loading...